𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Soluble interleukin-2 receptors in patients with systemic sclerosis

✍ Scribed by Dimitrios Degiannis; James R. Seibold; Margaret Czarnecki; Jana Raskova; Karel Raska Jr

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
530 KB
Volume
33
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of interleukin-21 receptor in
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis
✍ JΓΆrg H. W. Distler; Astrid JΓΌngel; Otylia Kowal-Bielecka; Beat A. Michel; Renate πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 2 views

## Abstract ## Objective To examine the expression and regulation of interleukin‐21 (IL‐21) and IL‐21 receptor (IL‐21R) in patients with systemic sclerosis (SSc; scleroderma). ## Methods Skin biopsy specimens were obtained from 23 patients with SSc and 15 healthy controls. IL‐21/IL‐21R messenger

Serum-soluble interleukin-2 receptor con
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer
✍ Saburo Murakami; Akira Safomi; Kiyoshi Lshida; Hideaki Murai; Moriyuki Mafsuki; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 369 KB πŸ‘ 2 views

Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo